These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7846526)

  • 1. Mexico. A stubborn amoeba takes center stage.
    Cohen J
    Science; 1995 Feb; 267(5199):822-4. PubMed ID: 7846526
    [No Abstract]   [Full Text] [Related]  

  • 2. Dispar makes its debut.
    Flemmer M; Oldfield EC
    Am J Gastroenterol; 1995 Aug; 90(8):1357. PubMed ID: 7639254
    [No Abstract]   [Full Text] [Related]  

  • 3. Entamoeba histolytica and/or Entamoeba dispar: infection frequency in HIV+/AIDS patients in Mexico city.
    Moran P; Ramos F; Ramiro M; Curiel O; González E; Valadez A; Gómez A; García G; Melendro EI; Ximénez C
    Exp Parasitol; 2005 Jul; 110(3):331-4. PubMed ID: 15955334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the redefinition of the agent of amoebiasis.
    Lucas R; Upcroft JA
    Rev Latinoam Microbiol; 2001; 43(4):183-7. PubMed ID: 17061507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence of Entamoeba histolytica: a challenge for human health research.
    Anaya-Velázquez F; Padilla-Vaca F
    Future Microbiol; 2011 Mar; 6(3):255-8. PubMed ID: 21449836
    [No Abstract]   [Full Text] [Related]  

  • 6. Entamoeba histolytica and Entamoeba dispar: prevalence infection in a rural Mexican community.
    Ramos F; Morán P; González E; García G; Ramiro M; Gómez A; de León Mdel C; Melendro EI; Valadez A; Ximénez C
    Exp Parasitol; 2005 Jul; 110(3):327-30. PubMed ID: 15955333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of pathogenic and non-pathogenic Entamoeba: has the question been answered?
    Mehlotra RK
    Indian J Gastroenterol; 1998 Apr; 17(2):58-60. PubMed ID: 9563222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of Entamoeba histolytica and Entamoeba dispar (Brumpt) infections on Mahé, the Seychelles.
    Sargeaunt PG
    Arch Med Res; 1992; 23(2):265-7. PubMed ID: 1340310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining entamoeba.
    Bhattacharya S; Bhattacharya A; Petri WA
    Trends Parasitol; 2002 May; 18(5):196-7. PubMed ID: 11983591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amebiasis: a problem solved. What now? Bernardo Sepúlveda Memorial lecture.
    Diamond LS
    Arch Med Res; 1992; 23(4):157-61. PubMed ID: 1308698
    [No Abstract]   [Full Text] [Related]  

  • 11. Revisiting amebiasis.
    Pillai DR
    Trends Parasitol; 2001 Feb; 17(2):64. PubMed ID: 11228009
    [No Abstract]   [Full Text] [Related]  

  • 12. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction.
    Tannich E
    Trans R Soc Trop Med Hyg; 1998; 92(6):593-6. PubMed ID: 10326098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of surface glycoconjugates on Entamoeba histolytica and Entamoeba dispar.
    Pacheco-Yépez J; Campos-Rodríguez R; Rojas-Hernández S; Serrano-Luna JJ; Rivera-Aguilar V; Villa-Treviño S; Martínez-Palomo A; Tsutsumi V; Shibayama M
    Parasitol Int; 2009 Jun; 58(2):171-7. PubMed ID: 19269346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of signalling and cytoskeletal rearrangements in the pathogenesis of Entamoeba histolytica.
    Guillén N
    Trends Microbiol; 1996 May; 4(5):191-7. PubMed ID: 8727599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entamoeba moshkovskii perspectives of a new agent to be considered in the diagnosis of amebiasis.
    Heredia RD; Fonseca JA; López MC
    Acta Trop; 2012 Sep; 123(3):139-45. PubMed ID: 22664420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of treatment of E. histolytica/E. dispar cyst carriers.
    Garduño-Espinosa J; Martínez-García MC; Valadez-Salazar A; Padilla G; Cedillo-Rivera R; Muñoz O
    Arch Med Res; 1997; 28 Spec No():293-4. PubMed ID: 9033106
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of human Entamoeba histolytica infection by zymodeme, indirect hemagglutination and electroimmunotransfer blot assays.
    Sánchez-Guillén MC; Argüello-García R; Garduño G; Valadez-Salazar A; Martínez-García MC; Muñoz O; Ortega-Pierres MG
    Arch Invest Med (Mex); 1990; 21 Suppl 1():209-15. PubMed ID: 2136487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lowering the peripheral level of 5-hydroxytryptamine in host on the virulence of Entamoeba histolytica.
    Ahmad I; Sen PC; Kulkarni RB; Sen MR
    Indian J Med Res; 1984 Jun; 79():741-3. PubMed ID: 6097538
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of Entamoeba histolytica and Entamoeba dispar from German travelers and residents of endemic areas.
    Walderich B; Weber A; Knobloch J
    Am J Trop Med Hyg; 1997 Jul; 57(1):70-4. PubMed ID: 9242322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response: Entamoeba infections in human immunodeficiency virus-infected patients: not just a tropical problem.
    Reed SL
    Clin Infect Dis; 2000 Jun; 30(6):959-61. PubMed ID: 10880315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.